In 2024, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused was US$58.9M.
In 2024, the states with the most international sales in Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Morelos (US$6.17M).
The states with the most international purchases in 2024 were Ciudad de México (US$10.2M), Nuevo León (US$7.94M), Jalisco (US$1.5M), Estado de México (US$1M), and Morelos (US$688k).
In 2024, the main commercial destinations of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were Ireland (US$4.87M), Netherlands (US$1.26M), Argentina (US$25.3k), Singapore (US$14k), and Brazil (US$10.6k).
The main commercial origins of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused in 2024 were Switzerland (US$8.46M), Spain (US$3.96M), India (US$3.87M), China (US$3.33M), and Argentina (US$1.3M).
In the global context, the main exporting countries of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused in 2022 were Switzerland (US$1.59B), Ireland (US$902M), and China (US$623M). In the same year, the main importing countries of Heterocyclic Compounds Containing in the Structure Cycle Thiazole, Incl. Hydrogenated Unfused were United States (US$1.34B), Canada (US$1.22B), and Brazil (US$385M).